TITLE OF THE DECREE
Decree of the Apostolic Penitentiary on the granting of special Indulgences to the faithful in the current pandemic, 20.03.2020
The gift of special Indulgences is granted to the faithful suffering from COVID-19 disease, commonly known as Coronavirus, as well as to health care workers, family members and all those who in any capacity, including through prayer, care for them.
“Be joyful in hope, patient in affliction, faithful in prayer” (Rom 12: 12). The words written by Saint Paul to the Church of Rome resonate throughout the entire history of the Church and guide the judgment of the faithful in the face of all suffering, sickness and calamity.
The present moment in which the whole of humanity, threatened by an invisible and insidious disease, which for some time now has become part of all our lives, is marked day after day by anguished fears, new uncertainties and above all widespread physical and moral suffering.
Whether convalescent plasma transfusion be beneficial in the treatment of critically ill patients with (COVID-19) disease
In an uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status.[JAMA Network ]
One investigational treatment being explored for COVID-19 involves the use of convalescent plasma collected from recovered COVID-19 patients. It is possible that convalescent plasma that contains antibodies to SARS-CoV-2 (the virus that causes COVID-19) might be effective against the infection. Use of convalescent plasma has been studied in outbreaks of other respiratory infections, including the 2009-2010 H1N1 influenza virus pandemic, 2003 SARS-CoV-1 epidemic, and the 2012 MERS-CoV epidemic. Although promising, convalescent plasma has not been shown to be effective in every disease studied. It is therefore important to determine through clinical trials, before routinely administering convalescent plasma to patients with COVID-19, that it is safe and effective to do so. Investigators wishing to study the use of convalescent plasma are encouraged to submit requests to FDA for investigational use under the traditional IND regulatory pathway (21 CFR 312).
These modifications to the Court’s Rules and practices do not apply to cases in which certiorari has been granted or a direct appeal or original action has been set for argument.
(ORDER LIST: 589 U.S.)
THURSDAY, MARCH 19, 2020
In light of the ongoing public health concerns relating to COVID-19, the following shall apply to cases prior to a ruling on a petition for a writ of certiorari:
IT IS ORDERED that the deadline to file any petition for a writ of certiorari due on or after the date of this order is extended to 150 days from the date of the lower court judgment, order denying discretionary review, or order denying a timely petition for rehearing. See Rules 13.1 and 13.3.
IT IS FURTHER ORDERED that motions for extensions of time pursuant to Rule 30.4 will ordinarily be granted by the Clerk as a matter of course if the grounds for the application are difficulties relating to COVID-19 and if the length of the extension requested is reasonable under the circumstances. Such motions should indicate whether the opposing party has an objection.
Hydroxychloroquine and azithromycin as a treatment of COVID‐19 (Severe acute respiratory syndrome coronavirus disease-2019 (COVID-19)
Hydroxychloroquine-(C18H26ClN3O)(Plaquenil) is used to prevent or treat malaria infections. This medication is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other medications have not worked or cannot be used. In the USA there are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. National Institute of Allergy and Infectious Diseases (NIAID) US in a statement mentioned that the study on Hydroxychloroquine in connection with COVID-19 is an adaptive, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19. The study is a multicenter trial that will be conducted in up to 50 sites globally. The study will be a series of 2-arm comparisons between different investigational therapeutic agents and a placebo. There will be interim monitoring to introduce new arms and allow early stopping for futility, efficacy, or safety. If one therapy proves to be efficacious, this treatment will then become the control arm for comparison(s) with new experimental treatment(s).
Hydroxychloroquine comes as a tablet (200mg per day) to take by mouth. For prevention of malaria in adults, two tablets are usually taken once a week on exactly the same day of each week. The first dose is taken 1 to 2 weeks before traveling to an area where malaria is common, and then doses are continued for 8 weeks after exposure. For treatment of acute attacks of malaria in adults, four tablets are usually taken right away, followed by two tablets 6 to 8 hours later and then two tablets on each of the next 2 days.
In India National task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive medication for COVID-19 and the same has been approved by Drug Controller General of India (DGCI).
In hospitalized patients with confirmed COVID-19 test cases, Hydroxychloroquine plus the antibiotic Azithromycin are given to COVID-19 patients. Azithromycin was added for its effectiveness against complications from bacterial lung disease. Robin May, Professor of Infectious Disease at the University of Birmingham UK, explained that there is a scientific rationale for the use of hydroxychloroquine in the treatment of COVID-19. Novel coronavirus (2019-nCoV, COVID-19) is a new virus that researchers first identified in Wuhan province, China, in late 2019.
Side effects of Hydroxychloroquine
loss of appetite
- International Journal of Antimicrobial Agents
- U.S. National Library of Medicine-National Center for Biotechnology Information
The discussion focused on the current economic situation in the context of the coronavirus pandemic and measures to support the real sector of the economy and the population.
21 March, Saturday 2020
Excerpts from the transcript:
Meeting on economic issues
Mikhail Mishustin: Good afternoon, colleagues,
I have asked you to meet here today to discuss the current situation. At present our economy is experiencing the impact of two negative factors – the coronavirus infection and a significant volatility of the stock markets as well as the global oil and gas markets. We are taking proactive preventive measures to reduce the impact on Russia’s financial system, on the real sector of the economy and the people.
We have adopted the Plan of Priority Measures to Ensure Sustainable Economic Development. The commission headed by Mr Belousov is working on this issue. We are acting jointly with the Bank of Russia. At the beginning of the week we took measures against the economic impact of the coronavirus and the volatility in the global financial and raw materials markets, whereas yesterday the Bank of Russia announced a set of measures to support citizens and the economy which complements and enhances the actions taken by the Government. I would like to thank our colleagues and you, Ms Nabiullina (addressing Elvira Nabiullina) for these prompt and professional actions.
Justice Gogoi, the first CJI from the north-east
CJI Gogoi has had a long and dynamic career since the time he was enrolled as a lawyer in the bar council in 1978. He was made the permanent judge of the Gauhati High Court on February 28, 2001. He was transferred to the Punjab and Haryana High Court on September 9, 2010, and became its Chief Justice on February 12, 2011. He was elevated as the judge of the SC on 23 April 2012 and will have a tenure of over seven years at the apex court till his retirement in November 2019. CJI Gogoi was born on November 18, 1954, in Guwahati in a politically influential family. His father, Keshab Chandra Gogoi, was a lawyer-turned-politician and served as chief minister of Assam for two months during the 1980s.
Name: Ranjan Gogoi [Ex-CJI]
Father: Kesab Chandra Gogoi (1925-1998), former Chief Minister of Assam (Indira Congress ) was a lawyer. As Congressman served as the ninth chief minister of Assam in 1982.
After a high powered committee meeting, Shree Jagannath Temple Administration (SJTA) on Sunday issued a health advisory for sevayats and the devotees. SJTA Chief Administrator Krishan Kumar said in a statement that the devotees will be allowed to enter the temple after filling up the self-declaration form about the travel history of their family members to foreign countries in the last 15 days. Besides, they will have to mention if any of the family members suffering from cough, cold and fever.
The regulations :
- The servitors will perform their duties while wearing a mask inside the temple.
- The servitors are advised to wash their hands repeatedly.
- They have been advised not to spit paan in public places.
- They are directed not to touch their eyes, nose and mouth during interaction with people.
- The devotees are prohibited from touching the Aruna Stambha, outside the temple.
Prohibitions on touching the Garuda Stambha inside the shrine have also been imposed.
- The devotees will be barred from darshan of deities from the Jagamohan.
- The darshan from Bhitar Katha will be closed till April 15.
- To maintain social distancing, the devotees will not be allowed to eat the Mahaprasad in Anand Bazar premises inside the temple.
Puri district collector Balwant Singh said steps are being taken to start thermal screening of devotees outside the temple. All the restrictions and regulations will remain in force till April 15
Guggul(Sanskrit Ayurvedic Term)
Guggul or Dhuna[fragrant balsamic resin] Commiphora Mukulor or Commiphora wightii , is generally used by the Bharatiya Hindus for Puja and Havan purpose. Guggul gum resin is also used by mouth for high cholesterol, “hardening of the arteries” (atherosclerosis), and weight loss in people who are obese or overweight. It is a natural air purifier. Guggul is usually prescribed as Ayurvedic remedies to help balance the three doshas- Bayu -Pitta -Kafa, Guggul has also been found to stimulate the thyroid gland. To this end, anyone with a thyroid condition should consult a doctor before using a guggul extract or supplement. [Guggul. Review of Natural Products. Facts & Comparisons [database online]. St. Louis, MO: Wolters Kluwer Health Inc; December 2011.[Caption Image- Guggul tree]
SUPREME COURT OF INDIA
05th March, 2020
It is notified for the information of all concerned that the Competent Authority has been pleased to direct that :
(i) With a view to bring uniformity about use of paper & printing thereon and to minimize consumption of paper & consequently to save the environment, superior quality A4 size paper (29.7 cm x 21 cm) having not less than 75 GSM with printing on both sides of the paper with Font – Times New Roman, Font size 14, in one and half line spacing (for quotations and indents – font size 12 in single line spacing), with margin of 4 cm on left & right and 2 cm on top & bottom, shall be used in the pleadings, petitions, affidavits or other documents to be filed in this Court;